Anti-VEGF/PD-1 bispecific antibody (Biox-Vision)

VEGF-PD1双特异性抗体（瀚海博兴）

Report date: 2025/02/19 10:40:19

Base Information

Drug NameAnti-VEGF/PD-1 bispecific antibody (Biox-Vision)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionVascular endothelial growth factor inhibitorsProgrammed cell death protein 1 blockers
TargetsVascular endothelial growth factorProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnhui Rubiox Vision Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Rubiox Vision Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A